EGFR and hepatocellular carcinoma: Taken together, our findings suggested that ZJP may inhibit HCC progression mainly via the regulation of cell proliferation and survival through the EGFR-MAPK, PI3K-NF-κB, and CCND1 signaling pathways (Figure 8).